Jyong Biotech opened lower at $1.72, compared with its previous close of $1.74. In the last trading session, the stock traded between $1.69 and $1.81. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 2 years ago in Jyong Biotech is now worth
$ 16.63
Resulting in a loss of
$ 83.37 (83.37%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
$-0.06 (-3.39%)
Day High
$1.81
Day Low
$1.69
Day Open
$1.72
Prev Close
$1.74
Volume
18,827
1W Return
-3.06%
1M Return
-18.99%
3M Return
-19.26%
6M Return
-18.79%
1Y Return
-95.87%
Fundamentals
Market Cap ($ Mn)
128
PE Ratio
-
PB Ratio
-
PEG Ratio
-
ROE
-
ROCE
34.60%
EPS (TTM)
-
Investment Returns
1 Week
-3.06%
1 Month
-18.99%
3 Months
-19.26%
6 Months
-18.79%
9 Months
15.14%
Financials
Quarterly
All values in $ Mn
No data available.
Updates
15Oct
Jyong Biotech plans Texas facility for US operations
Jyong Biotech plans a manufacturing facility and U.S. operations center in Texas. Site selection driven by land costs, tax structures, and workforce availability. Facility intended to support commercialization of proprietary drug candidates. Company submitted plans to local authorities and awaits regulatory communication.
28 days ago
2Jul
Jyong Biotech advances Botreso licensing at BIO 2026
Jyong Biotech Ltd. participated in BIO 2026 to advance global licensing for its botanical drug Botreso, which targets BPH and LUTS. The company has completed four Phase III trials and is accelerating NDA preparations amid a projected 35-40% market growth by 2035. Jyong Biotech aims to commercialize the drug through regional partnerships in the US, Europe, and Asia.
